iSAM Funds (UK)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$295K Sell
4,703
-1,910
-29% -$153K 0.15% 213
2025
Q4
$631K Sell
6,613
-8,466
-56% -$830K 0.23% 130
2025
Q3
$1.47M Buy
+15,079
New +$1.56M 0.3% 93
2025
Q2
Sell
-12,664
Closed -$1.28M 464
2025
Q1
$1.28M Buy
12,664
+9,171
+263% +$923K 0.63% 39
2024
Q4
$312K Sell
3,493
-18,473
-84% -$1.63M 0.23% 177
2024
Q3
$1.84M Buy
21,966
+12,972
+144% +$1.02M 1.04% 10
2024
Q2
$693K Buy
+8,994
New +$658K 0.52% 67
2024
Q1
Sell
-20,241
Closed -$1.17M 251
2023
Q4
$1.17M Buy
+20,241
New +$1.08M 0.83% 41
2023
Q3
Sell
-32,804
Closed -$1.77M 236
2023
Q2
$1.77M Buy
+32,804
New +$1.71M 1.59% 7
2023
Q1
Sell
-17,053
Closed -$789K 161
2022
Q4
$789K Buy
+17,053
New +$738K 2.36% 6

Other funds holding BSX

iSAM Funds (UK)'s BSX Position: Q1 2026 in Review

iSAM Funds (UK) reduced its Boston Scientific (BSX) stake by 29% in Q1 2026, selling an estimated $153K and leaving 4,703 shares worth $295K. The position accounts for 0.15% of the portfolio, ranked #213.

iSAM Funds (UK) first reported a position in BSX in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.84M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • iSAM Funds (UK) held 4,703 shares of Boston Scientific worth $295K as of Q1 2026.
  • iSAM Funds (UK) sold 1,910 Boston Scientific shares in Q1 2026, an estimated $153K.
  • Boston Scientific made up 0.15% of iSAM Funds (UK)'s portfolio in Q1 2026, its #213 holding.
  • iSAM Funds (UK) first reported a position in Boston Scientific in Q4 2022 and has held it in 10 quarters since.
  • iSAM Funds (UK)'s Boston Scientific position peaked at $1.84M in Q3 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on iSAM Funds (UK)'s 13F filing for Q1 2026, filed 13 May 2026.